First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary studyYing Liu, Jufeng Wang, Ke Li et al.|International Journal of Clinical Oncology|2015Cited by 31